Ondibta
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Ondibta, covering 2026-04-24 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Ondibta (insulin glargine) — Sandoz GmbH
3 regulatory and trial events tracked for Ondibta, covering 2026-04-24 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Ondibta (insulin glargine) — Sandoz GmbH